學術產出-學位論文

文章檢視/開啟

書目匯出

Google ScholarTM

政大圖書館

引文資訊

TAIR相關學術產出

題名 Genedex co. 營運計畫書
Genedex co. business plan
作者 王熙婷
Wang, Kate
貢獻者 蔡政憲
Tsai, Jason
王熙婷
Wang, Kate
關鍵詞 OTC藥品分割
人口高齡化
學名藥
OTC drugs segment
Aging population
Generic drugs
日期 2017
上傳時間 1-十二月-2017 12:07:34 (UTC+8)
摘要 Aging population is becoming the potential social and economic problem for many governments all around the world. These countries including Taiwan are seeking for solutions for the increased healthcare spending. According to the United Nations’ population estimates, we are living in a rapidly aging world. The global share of what we call “senior” or people age over 65 is expected to rise from nearly 8% in 2015 to more than 14% by 2050. The situation in Taiwan is not much different. With increasing life expectancy and a birth rate that continues to decline, the aging population in Taiwan has become more and more obvious.
Widespread adoption of Generic and Biosimilar drugs, as opposed to patented or brand name drugs, could help governments reduce healthcare costs and increase the reach of healthcare services. Patented drugs in the prescription drugs segment account for about 70% of total prescription spending in Taiwan. However, the share is set to decline gradually under pressure from government policies promoting the use of generic products and the increasing switches from prescription segment to OTC segment (RX-to-OTC). We expect the penetration of generic drugs in Taiwan OTC drugs segment to increase as the generic drug market has continued to gain prominence within the pharmaceutical sectors in recent years.
Despite the fact that OTC generic drug market is a highly competitive market in Taiwan, Genedex Co. still aims to provide good quality generic drugs at a competitive price to meet the generic drugs demands. In addition, Genedex Co. understands the ability to quickly bring new products to the market will play a large role in the future success. Thus, product innovation and differentiation will also be the center focus in the business model. Looking into the future, Genedex Co. expects to see growth at a more rapid pace starting from year 2020 as newly developed generic OTC drugs will be introduced to the market to compete with the branded counterparts and also expects to achieve a more solid presence in the market by year 2021.
參考文獻 IMS Health. http://www.imshealth.com/. Accessed August 2017.
Industry & Technology Intelligence Service. http://www.itis.org.tw/Default.aspx . Accessed August 2017.
KHS. https://www.gmdu.net/corp-831310.html. Accessed August 2017.
Market Data Forecast. Market Data Forecast 2016 report. http://www.marketdataforecast.com/. Accessed August 2017.
Shiner Pharm Corp. http://www.shinerpharm.com/about-us/ Accessed August 2017.
Taiwan Directorate general of Budget Accounting and Statistics (DGBAS). http://eng.dgbas.gov.tw/mp.asp?mp=2. Accessed August 2017.
United Nations. 2015. UN Global Population Prospects Report, 2015 Revision. https://esa.un.org/unpd/wpp/Publications/. Accessed August 2017.
台灣製藥工業同業公會. http://www.tpma.org.tw/. Accessed August 2017.
描述 碩士
國立政治大學
國際經營管理英語碩士學位學程(IMBA)
102933013
資料來源 http://thesis.lib.nccu.edu.tw/record/#G0102933013
資料類型 thesis
dc.contributor.advisor 蔡政憲zh_TW
dc.contributor.advisor Tsai, Jasonen_US
dc.contributor.author (作者) 王熙婷zh_TW
dc.contributor.author (作者) Wang, Kateen_US
dc.creator (作者) 王熙婷zh_TW
dc.creator (作者) Wang, Kateen_US
dc.date (日期) 2017en_US
dc.date.accessioned 1-十二月-2017 12:07:34 (UTC+8)-
dc.date.available 1-十二月-2017 12:07:34 (UTC+8)-
dc.date.issued (上傳時間) 1-十二月-2017 12:07:34 (UTC+8)-
dc.identifier (其他 識別碼) G0102933013en_US
dc.identifier.uri (URI) http://nccur.lib.nccu.edu.tw/handle/140.119/114964-
dc.description (描述) 碩士zh_TW
dc.description (描述) 國立政治大學zh_TW
dc.description (描述) 國際經營管理英語碩士學位學程(IMBA)zh_TW
dc.description (描述) 102933013zh_TW
dc.description.abstract (摘要) Aging population is becoming the potential social and economic problem for many governments all around the world. These countries including Taiwan are seeking for solutions for the increased healthcare spending. According to the United Nations’ population estimates, we are living in a rapidly aging world. The global share of what we call “senior” or people age over 65 is expected to rise from nearly 8% in 2015 to more than 14% by 2050. The situation in Taiwan is not much different. With increasing life expectancy and a birth rate that continues to decline, the aging population in Taiwan has become more and more obvious.
Widespread adoption of Generic and Biosimilar drugs, as opposed to patented or brand name drugs, could help governments reduce healthcare costs and increase the reach of healthcare services. Patented drugs in the prescription drugs segment account for about 70% of total prescription spending in Taiwan. However, the share is set to decline gradually under pressure from government policies promoting the use of generic products and the increasing switches from prescription segment to OTC segment (RX-to-OTC). We expect the penetration of generic drugs in Taiwan OTC drugs segment to increase as the generic drug market has continued to gain prominence within the pharmaceutical sectors in recent years.
Despite the fact that OTC generic drug market is a highly competitive market in Taiwan, Genedex Co. still aims to provide good quality generic drugs at a competitive price to meet the generic drugs demands. In addition, Genedex Co. understands the ability to quickly bring new products to the market will play a large role in the future success. Thus, product innovation and differentiation will also be the center focus in the business model. Looking into the future, Genedex Co. expects to see growth at a more rapid pace starting from year 2020 as newly developed generic OTC drugs will be introduced to the market to compete with the branded counterparts and also expects to achieve a more solid presence in the market by year 2021.
en_US
dc.description.tableofcontents 1 Executive Summary & Company Overview 1
2 Market Opportunity 2
3 Over-the-Counter (OTC) Drugs Market in Taiwan 4
3.1 What is Over-the-Counter drugs? 4
3.2 Categories of OTC Drugs in Taiwan 5
3.3 OTC Drugs Market Size 7
3.4 Major Competitors in Taiwan OTC Drugs Market 10
3.5 Why do we pick OTC Drug Market to enter? 14
4 Business Model 16
5 OTC Drugs Design & Development Plan 18
5.1 OTC Drug Products – Ready for Sales 18
5.2 OTC Drug Products – Under Development 22
6 Market Distribution: Pharmacies/Drugstores in Taiwan 25
7 Financial Forecast Simulation 26
8 Future Prospects 28
Reference 30
zh_TW
dc.source.uri (資料來源) http://thesis.lib.nccu.edu.tw/record/#G0102933013en_US
dc.subject (關鍵詞) OTC藥品分割zh_TW
dc.subject (關鍵詞) 人口高齡化zh_TW
dc.subject (關鍵詞) 學名藥zh_TW
dc.subject (關鍵詞) OTC drugs segmenten_US
dc.subject (關鍵詞) Aging populationen_US
dc.subject (關鍵詞) Generic drugsen_US
dc.title (題名) Genedex co. 營運計畫書zh_TW
dc.title (題名) Genedex co. business planen_US
dc.type (資料類型) thesisen_US
dc.relation.reference (參考文獻) IMS Health. http://www.imshealth.com/. Accessed August 2017.
Industry & Technology Intelligence Service. http://www.itis.org.tw/Default.aspx . Accessed August 2017.
KHS. https://www.gmdu.net/corp-831310.html. Accessed August 2017.
Market Data Forecast. Market Data Forecast 2016 report. http://www.marketdataforecast.com/. Accessed August 2017.
Shiner Pharm Corp. http://www.shinerpharm.com/about-us/ Accessed August 2017.
Taiwan Directorate general of Budget Accounting and Statistics (DGBAS). http://eng.dgbas.gov.tw/mp.asp?mp=2. Accessed August 2017.
United Nations. 2015. UN Global Population Prospects Report, 2015 Revision. https://esa.un.org/unpd/wpp/Publications/. Accessed August 2017.
台灣製藥工業同業公會. http://www.tpma.org.tw/. Accessed August 2017.
zh_TW